Study guide
13.4 Amino Acids & Proteins: Structure, Properties, Separation, Specialized Products, Collagen & Protein Misfolding in Alzheimer Disease
Philippine Physician Licensure Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: PLE Structure, Eligibility & Study Strategy
1.1 PLE Format, 2026 Schedule & the Statutory Passing Rule 1.2 Eligibility, Internship, PRC Filing & Test-Day Rules 1.3 Reading the 2025 Tables of Specifications & Building a Study Plan
2 Chapter 2: Physiology I: Cells, Blood, Nerve & Muscle
2.1 Homeostasis, Cell Function, Membrane Transport & Resting Potential 2.2 Blood Cells, Immunity, Hemostasis, Fibrinolysis & Blood Distribution 2.3 Action Potentials, Conduction, the Neuromuscular Junction & Muscle Contraction
3 Chapter 3: Physiology II: Cardiovascular & Respiratory Systems
3.1 Cardiac Electrophysiology, the Cardiac Cycle & the Heart as a Pump 3.2 Circulation: Resistance, Venous Return, Coronary Flow, Microcirculation & Fetal Circulation 3.3 Respiratory Mechanics, Gas Exchange, Gas Transport, Control of Breathing & Extreme Environments
4 Chapter 4: Physiology III: Gastrointestinal, Endocrine, Renal & Reproductive Systems
4.1 Gastrointestinal Physiology: Secretion, Motility, Digestion & Absorption 4.2 Endocrine Physiology: Hormone Chemistry, Axes, Calcium & Fuel Regulation 4.3 Renal Physiology, Body Fluid Balance & Acid-Base Regulation 4.4 Reproductive Physiology: Sexual Differentiation, Spermatogenesis, the Menstrual Cycle, Parturition & Lactation
5 Chapter 5: Physiology IV: Neurophysiology & Special Senses
5.1 Sensory Receptors, Somatic Sensation, Spinal Reflexes & Motor Control 5.2 Higher Brain Functions, Sleep, the Autonomic Nervous System, Cerebral Blood Flow & the Special Senses
6 Chapter 6: Legal Medicine I: Medicolegal Examination, Identification & Death
6.1 The Medicolegal Examination, Physical Evidence & the Crime Scene 6.2 Identification of the Living, the Dead & Skeletal Remains 6.3 Thanatology: Death, Brain Death, Postmortem Changes & Time of Death
7 Chapter 7: Legal Medicine II: Injuries, Sexual Crimes, Reproduction, Mental State & Poisoning
7.1 Physical Injuries: Revised Penal Code Classes, Wounds, Gunshot Injuries, Asphyxia & Burns 7.2 Sexual Crimes, Violence Against Women & Child Abuse 7.3 Medicolegal Aspects of Pregnancy, Delivery, Abortion, Infanticide, Paternity & Marriage 7.4 Disturbance of Mentality: Insanity, Intoxication, Capacity & the Mental Health Act 7.5 Forensic Toxicology & Poisoning: Diagnosis, Evidence, Antidotes & Philippine Laws
8 Chapter 8: Legal Medicine III: Reports, Regulation, Liability & Ethics
8.1 The Medicolegal Report, the Death Certificate, Autopsy Rules & Communicating with Relatives 8.2 Licensure & Regulation of Medical Practice: RA 2382, the Board of Medicine, PRC & Prescribing Laws 8.3 Medical Malpractice: Civil, Criminal & Administrative Liability and Key Philippine Doctrines 8.4 Physician Relationships Under the PMA Code of Ethics: Patients, Colleagues, Allied Health, Students, Industry, HMOs, Hospitals & PhilHealth 8.5 Bioethical Principles, Informed Consent, Confidentiality, End-of-Life & Research Ethics
9 Chapter 9: Pathology I: Cell Injury, Inflammation & Hemodynamics
9.1 Cell Injury, Adaptation, Necrosis, Apoptosis, Accumulations & Calcification 9.2 Acute & Chronic Inflammation, Granulomas, Systemic Effects & Tissue Repair 9.3 Hemodynamic Disorders: Edema, Hemorrhage, Thrombosis, Embolism, Infarction, DIC & Shock
10 Chapter 10: Pathology II: Genetics, Neoplasia, Immunity, Environment & Infection
10.1 Genetic Disorders & Neoplasia: Mendelian, Chromosomal, Non-Classic Inheritance, Tumor Biology & Markers 10.2 Immunopathology: Hypersensitivity, Autoimmunity, Immunodeficiency & Transplant Rejection 10.3 Environmental & Nutritional Pathology: Air Pollution, Tobacco, Metals, Occupational Lung Disease & Deficiency States 10.4 Pathology of Infectious Diseases: Transmission, Tissue Reaction Patterns & Diagnostic Morphology
11 Chapter 11: Pathology III: Gastrointestinal, Cardiovascular & Respiratory Pathology
11.1 Gastrointestinal, Hepatic, Biliary & Pancreatic Pathology 11.2 Cardiovascular & Collagen Pathology: Heart Failure, Congenital, Ischemic, Hypertensive, Valvular, Pericardial & Myocardial Disease 11.3 Respiratory Pathology: Atelectasis, Edema, ARDS, Obstructive & Restrictive Disease, Vascular Disease, Infections, Tumors & Pleura
12 Chapter 12: Pathology IV: Hematopoietic, Genitourinary, Endocrine & Nervous System Pathology
12.1 Hematopoietic Pathology: Anemias, Polycythemia, Bleeding Disorders, DIC & Lymphoid and Myeloid Neoplasms 12.2 Genitourinary Pathology: Glomerular, Tubulointerstitial, Vascular & Cystic Kidney Disease, Renal Tumors, Obstruction & Genital Disorders 12.3 Endocrine Pathology: Pancreas, Adrenal, Parathyroid, Thyroid & Pituitary Disorders 12.4 Nervous System Pathology: Cerebrovascular Disease, Edema & Herniation, Infections, Degenerative & Demyelinating Disease, Tumors
13 Chapter 13: Biochemistry I: Carbohydrate, Protein, Genetic & Energy Biochemistry
13.1 Carbohydrate Chemistry, Digestion, Glycolysis, Pyruvate Dehydrogenase & the Pentose Phosphate Pathway 13.2 Gluconeogenesis, Glycogen, Lipogenesis, Ketogenesis & Hormonal Control of Fuel Metabolism 13.3 Protein Digestion, Amino Acid Catabolism, the Urea Cycle, Heme Synthesis, Porphyrias & Bilirubin Metabolism 13.4 Amino Acids & Proteins: Structure, Properties, Separation, Specialized Products, Collagen & Protein Misfolding in Alzheimer Disease 13.5 Molecular Genetics & Enzymes: Replication, Repair, Gene Expression, Molecular Techniques, Lysosomal Storage Diseases & Enzyme Kinetics 13.6 Bioenergetics, the Citric Acid Cycle, Oxidative Phosphorylation, Muscle Energetics & Nucleotide Metabolism
14 Chapter 14: Biochemistry II: Respiratory, Nutritional, Immunologic & Cardiovascular Biochemistry
14.1 Respiratory Biochemistry: Hemoglobin, Oxygen Binding, Hemoglobinopathies, Thalassemias, Methemoglobin, Buffers & Acid-Base Balance 14.2 Nutrition Biochemistry: Dietary Standards (RENI to PDRI 2015), Food Guides, Protein Quality, Energy Expenditure, Breast Milk, Vitamins, Minerals & Blood Components 14.3 Immunology: Innate & Adaptive Immunity, the Immune Response, Antibodies, Complement, Cytokines & MHC 14.4 Cardiovascular Biochemistry: Cholesterol, Lipoproteins, Dyslipidemias, Atherogenesis, Myocardial Energetics, Biomarkers & Heart Failure
15 Chapter 15: Anatomy I: Thorax, Abdomen, Pelvis & Back
15.1 Thorax: Thoracic Wall, Breast, Pleura & Lungs, Mediastinum, Heart & Great Vessels 15.2 Abdomen: Abdominal Wall & Inguinal Region, Peritoneum, Viscera, Diaphragm & Posterior Abdominal Wall 15.3 Pelvis & Perineum: Bony Pelvis, Pelvic Floor, Pelvic Viscera, Vessels & Nerves, Perineal Pouches & the Anal Canal 15.4 Back & Spinal Column: Vertebrae, Curvatures, Joints, Back Muscles, Spinal Cord, Meninges & Cord Syndromes
16 Chapter 16: Anatomy II: Upper Limb, Lower Limb & Skin
16.1 Upper Limb: Bones, Superficial Veins, Shoulder Muscles, Axilla & Brachial Plexus, Arm, Cubital Fossa, Forearm, Hand & Joints 16.2 Lower Limb: Bones, Venous & Lymphatic Drainage, Thigh, Gluteal Region, Popliteal Fossa, Leg Compartments, Foot, Joints & Gait 16.3 Skin & Appendages: Epidermis, Junctions, Dermis, Subcutaneous Tissue, Fascia, Nerves, Vessels, Lymphatics, Hair, Nails & Glands
17 Chapter 17: Anatomy III: Head, Neck & Histology
17.1 Head I: Skull & Cranial Foramina, Scalp, Face & Parotid, Orbit, Temporal & Infratemporal Fossae, TMJ, Oral Region, Nose & Ear 17.2 Head II: Meninges & Dural Venous Sinuses, Brain Regions & Ventricles, Blood Supply, Cranial Nerves, Pituitary & Pineal, Brainstem Syndromes 17.3 Neck: Cervical Vertebrae & Hyoid, Fascial Layers, Superficial Muscles, Triangles, Root of the Neck, Visceral Layers & Lymphatics 17.4 Histology: Cells, Epithelium & Glands, Connective Tissue & Fat, Cartilage & Bone, Blood & Hematopoiesis, Muscle, Nerve, Vessels, Lymphoid Organs & Organ Histology
18 Chapter 18: Microbiology I: Foundations, Respiratory & Cardiovascular Infections
18.1 Microbiology Foundations: The Organ-System TOS, Specimens & Stains, Gram-Positive and Gram-Negative Bacteria 18.2 Respiratory Infections: Tonsillitis, Sinusitis & Mastoiditis, Bronchitis, Community-Acquired & Severe Pneumonia, Bronchiectasis and Paragonimiasis 18.3 Tuberculosis, Leprosy & Nontuberculous Mycobacteria: Pathogenesis, Diagnosis, NTP Regimens & Prevention 18.4 Cardiovascular Infections: Infective Endocarditis, Rheumatic Fever & Rheumatic Heart Disease, Myocarditis, Pericarditis and Septic Thrombophlebitis
19 Chapter 19: Microbiology II: Gastrointestinal & Nervous System Infections
19.1 Gastrointestinal Infections I: Gastroenteritis & Enterocolitis, Cholera, Typhoid & Salmonellosis, Shigellosis, Food Poisoning and Viral Hepatitis 19.2 Gastrointestinal Infections II: Amebiasis, Giardiasis & Cryptosporidiosis, Soil-Transmitted Helminths, Pinworm, Capillariasis and Tapeworms 19.3 Nervous System Infections: Meningitis & CSF Patterns, Encephalitis, Rabies and DOH PEP, Spinal Cord Infections, Tetanus & Botulism, Paralytic Shellfish Poisoning
20 Chapter 20: Microbiology III: Genitourinary, Reproductive, Blood & Skin Infections
20.1 Genitourinary Infections: Cystitis & Pyelonephritis, Urine Diagnostics, Urethritis, Balanoposthitis, Pelvic Inflammatory Disease and Genital Ulcers 20.2 Reproductive Tract Infections & STIs: Syphilis, Genital & Neonatal Herpes, HPV, Molluscum, CMV, Trichomoniasis & Vaginitis, Cervicitis, Prostatitis and Orchitis 20.3 Hematopoietic & Lymphatic Infections: Dengue and Other Hemorrhagic Fevers, Malaria, Lymphatic Filariasis, Lymphogranuloma Venereum and Epstein-Barr Virus 20.4 Integumentary Infections: Viral Exanthems (Measles, Mumps, Rubella, Varicella, Smallpox & Mpox, Fifth Disease), Herpesviruses, Fungal Skin Infections and Tick-Borne Diseases
21 Chapter 21: Microbiology IV: Musculoskeletal & Multisystemic Infections
21.1 Musculoskeletal & Soft-Tissue Infections: Osteomyelitis, Septic & Reactive Arthritis, Pyomyositis & Gas Gangrene, Cellulitis, Necrotizing Fasciitis and Bite Wounds 21.2 Multisystemic Infections I: Septicemia, Septicopyemia & Septic Shock, Leptospirosis and Schistosomiasis japonica 21.3 Multisystemic Infections II: HIV/AIDS Virology, the Philippine Epidemic & RA 11166, Diagnosis (rHIVda), ART, Prevention and Opportunistic Infections including Toxoplasmosis
22 Chapter 22: Obstetrics I: Prenatal Care, Labor & Obstetric Bleeding
22.1 Prenatal Care: Diagnosis of Pregnancy, Maternal Physiology, Dating, Nutrition & Supplements, Screening Tests and the DOH Antenatal Package 22.2 Labor & Parturition: Signs of Labor, Pelvis and Passenger, Stages and Cardinal Movements, Partograph, Fetal Monitoring, Dystocia, Shoulder Dystocia, Operative Delivery, Preterm Labor, PROM and Adolescent Pregnancy 22.3 Early Pregnancy Risks & Bleeding: Hyperemesis, Spontaneous Abortion, Recurrent Loss & Cervical Insufficiency, Ectopic Pregnancy, Hydatidiform Mole & Gestational Trophoblastic Neoplasia 22.4 Hemorrhagic Complications of Pregnancy: Placenta Previa, Abruption, Vasa Previa, Placenta Accreta Spectrum, Uterine Rupture, Third-Stage Management and Postpartum Hemorrhage
23 Chapter 23: Obstetrics II: Fetal, Hypertensive, Medical, Infectious & Postpartum Problems
23.1 Fetal Complications: Malpresentation & Breech, Macrosomia, Fetal Growth Restriction, Amniotic Fluid Disorders, Antepartum Surveillance, Rh Alloimmunization, Multiple Gestation and Post-Term Pregnancy 23.2 Hypertension & Diabetes in Pregnancy: Classification, Preeclampsia Pathogenesis and Prevention, Severe Features, Eclampsia & HELLP, Magnesium Sulfate, Gestational and Pregestational Diabetes 23.3 Medical & Surgical Disorders in Pregnancy: Drug Pharmacokinetics, Epilepsy, Thyroid, Heart Disease, SLE & APS, Asthma, Liver Disorders, Anemia, Dermatoses, Appendicitis, Gallstones, Stones and Trauma 23.4 Perinatal Infections: Triple Elimination (HIV, Syphilis, Hepatitis B), Group B Streptococcus, Chorioamnionitis, Gonorrhea & Chlamydia, Condyloma, Herpes and the TORCH Infections 23.5 Postpartum Care & Complications: Normal Puerperium, Postnatal Visits, Breastfeeding, Puerperal Fever and Infection, Mastitis, Late Hemorrhage, Mood Disorders, VTE and Postpartum Contraception
24 Chapter 24: Gynecology I: Benign Disorders, Infections & Contraception
24.1 Benign Lower Genital Tract Disorders & Pelvic Floor: Vulvar Dermatoses, Bartholin Cysts, Vaginal and Cervical Lesions, Premalignant Lesions, Pelvic Organ Prolapse, Urinary Incontinence and Fistula 24.2 Benign Upper Genital Tract Disorders: Leiomyoma, Adenomyosis & Endometriosis, Endometrial Polyps and Hyperplasia, Functional Cysts and Benign Ovarian Tumors, Adnexal Torsion and Tubal Disease 24.3 Infections of the Female Reproductive Tract: Burden & Screening, Syndromic Management, Vaginitis and Cervicitis, Pelvic Inflammatory Disease & Tubo-Ovarian Abscess, Genital Tuberculosis and Toxic Shock 24.4 Contraception & Family Planning: The RH Law, Effectiveness, Natural and Barrier Methods, Hormonal Methods, IUDs, Permanent Methods, Emergency Contraception and the WHO Eligibility Criteria
25 Chapter 25: Gynecology II: Reproductive Endocrinology, Oncology & Special Issues
25.1 Reproductive Endocrinology & Menstrual Disorders: The Menstrual Cycle, Puberty, Abnormal Uterine Bleeding (PALM-COEIN), Amenorrhea, PCOS, Hyperprolactinemia, Dysmenorrhea, Infertility, Menopause, HRT and Osteoporosis 25.2 Gynecologic Oncology: Cervical Cancer Screening, Staging & Treatment, Endometrial Cancer and Lynch Syndrome, Ovarian Tumors and BRCA, Vulvar and Vaginal Cancer, Survival and Quality of Life 25.3 Contemporary Issues & Pediatric and Adolescent Gynecology: Violence Against Women, Sexual Assault Care, Breast Disorders, Ethics of Maternal-Fetal Conflict, and Gynecologic Problems of Children and Adolescents
26 Chapter 26: Pediatrics I: Newborn, Growth, Nutrition, Immunization & Infections
26.1 The Newborn: Normal Findings and Variants, EINC (Unang Yakap), APGAR, Neonatal Resuscitation, Routine Care & Newborn Screening, Jaundice, Respiratory Distress, Hypoglycemia and Neonatal Sepsis 26.2 Growth, Development & Nutrition: Growth Parameters, Milestones and Red Flags, Speech Delay, Autism, ADHD & Global Delay, Breastfeeding and Feeding, Micronutrient Deficiencies, Malnutrition and Obesity 26.3 Immunization: RA 10152 and the National Immunization Program Schedule, Fully Immunized Child, School-Based Immunization, Other Recommended Vaccines, Vaccine Types, Cold Chain, Contraindications and AEFI 26.4 Pediatric Infectious Diseases: Bacterial (Diphtheria to Congenital Syphilis), Childhood TB, Viral Exanthems and Infections, Dengue in Children, Pediatric HIV, Protozoal, Helminthic and Fungal Infections
27 Chapter 27: Pediatrics II: Respiratory, Cardiovascular, Neurologic & Gastrointestinal Disorders
27.1 Pediatric Respiratory Disorders: IMCI Danger Signs and Cough Assessment, URI, Tonsillitis & Peritonsillar Abscess, Croup, Epiglottitis, Foreign Body, Bronchiolitis, Pneumonia, Pleural Effusion and Complications 27.2 Pediatric Cardiovascular & Collagen Disorders: Heart Sounds and Murmurs, Acyanotic and Cyanotic Congenital Heart Disease, Eisenmenger, Hypercyanotic Spells, Heart Failure, Rheumatic Fever, Hypertension, Endocarditis, Kawasaki, SLE, JIA, Dermatomyositis and Pediatric Resuscitation 27.3 Pediatric CNS Disorders: Febrile Seizures, Epilepsy Syndromes, Status Epilepticus, Meningitis and Encephalitis in Children, Cerebral Palsy, Hydrocephalus & Neural Tube Defects, Headache and Migraine, and Brain Tumors 27.4 Pediatric GI Disorders & Poisoning: Vomiting (Pyloric Stenosis, Atresias, Malrotation, Intussusception, GERD), Diarrhea and IMCI Rehydration Plans, Abdominal Pain, Constipation & Hirschsprung, Jaundice, Biliary Atresia & Choledochal Cyst, Hepatitis, Food Allergy, and Kerosene, Aspirin and INH Poisoning
28 Chapter 28: Pediatrics III: Genitourinary, Endocrine, Hematologic & Oncologic Disorders
28.1 Pediatric Genitourinary Disorders & Child Abuse: UTI and Vesicoureteral Reflux, Post-Streptococcal GN and Other Nephritides, Nephrotic Syndrome, AKI and HUS, CKD, Congenital Urogenital Anomalies, and Recognizing and Reporting Child Abuse 28.2 Pediatric Endocrine & Metabolic Disorders: Short Stature and Growth Hormone, Gigantism, Diabetes Insipidus, Congenital Hypothyroidism, Graves Disease & Goiter, Type 1 Diabetes and DKA, Congenital Adrenal Hyperplasia, Cushing Syndrome, Pheochromocytoma and Adrenal Crisis 28.3 Pediatric Hematology, Allergy & Immunology: Normal Hemogram and Immunoglobulins by Age, Anemias (Iron Deficiency, Thalassemia, G6PD, Spherocytosis, Aplastic), Bleeding Disorders (ITP, Hemophilia, vWD, DIC, Vitamin K), IgA Vasculitis, Rashes and Drug Reactions, Asthma, Allergic Rhinitis and Primary Immunodeficiencies 28.4 Pediatric Oncology & Genetics: Leukemias and Lymphomas, Retinoblastoma, Wilms Tumor, Neuroblastoma, Ewing Sarcoma and Osteosarcoma; Sex Chromosome and Autosomal Disorders, Inborn Errors of Metabolism and the Dysmorphic ("Odd-Looking") Child
29 Chapter 29: Preventive Medicine I: The Physician as Health Care Provider
29.1 The Physician as Health Care Provider I: Natural History of Disease, Disease Causation, Levels of Prevention and Primary Care Across the Clinical Rotations 29.2 The Physician as Health Care Provider II: The Filipino Family and Family Assessment Tools, Health Education and Promotion, Behavior Change Models and Geriatric Medicine 29.3 The Physician as Health Care Provider III: The Primary Health Care Concept (Alma-Ata, Astana, Philippine PHC) and Mental Health in Primary Care under RA 11036
30 Chapter 30: Preventive Medicine II: Philippine Health Care System & Community Medicine
30.1 The Philippine Health Care System: DOH Structure, Levels of Care and Referral, Devolution under RA 7160, the Universal Health Care Act (RA 11223), PhilHealth and YAKAP, and Leading Causes of Morbidity and Mortality 30.2 Epidemiology, Surveillance & Outbreaks: Measures of Disease Occurrence and Association, Rates, Endemic and Epidemic Levels, PIDSR and RA 11332 Notifiable Diseases, the Ten Steps of Outbreak Investigation and Epidemic Curves 30.3 DOH Programs & Environmental Sanitation: TB, Dengue, Rabies, Leprosy, Helminth and Other Disease Programs; the Sanitation Code (PD 856), Water Supply and Potability, Excreta and Solid Waste, Food Sanitation and Health Care Waste 30.4 Community Medicine: Principles of Public Health Administration and Program Planning, Vital Health Indices (Infant and Maternal Mortality), the Ecologic Concept of Health, Lifestyle and Non-Communicable Diseases, Health-Seeking Behavior and Traditional Medicine
31 Chapter 31: Preventive Medicine III: Manager, Researcher & Social Mobilizer
31.1 The Physician as Administrative Manager: Communication and Interpersonal Skills, Teamwork, Adult Learning, Occupational Health (RA 11058), Bioethics, Palliative Care, School Health, Organ Transplantation and Birth and Death Certificates 31.2 The Physician as Researcher I: The Research Process and Proposal, Research Ethics, Study Designs and Meta-Analysis, Demography and Vital Statistics, Evidence-Based Medicine and Quality Assurance 31.3 The Physician as Researcher II: Biostatistics (Data Types, Distributions, Central Tendency and Dispersion, Confidence Intervals, Hypothesis Testing and Test Selection) and Screening Tests (Validity, Predictive Values, Likelihood Ratios, Biases and Program Criteria) 31.4 The Physician as Social Mobilizer and Leader: Philippine Health Laws, Decrees and Executive Orders, Principles of Social Mobilization and Community Organizing, and Disaster Risk Reduction and Management in Health
32 Chapter 32: Pharmacology I: Principles, Cardiovascular & Nervous System Therapeutics
32.1 Pharmacology Foundations: The Pharmacology TOS, Pharmacokinetics, Drug Metabolism and Interactions, Pharmacodynamics, Adverse Drug Reactions and Monitoring, Autonomic Pharmacology, and Philippine Prescribing Rules 32.2 Cardiovascular Pharmacology I: Cardiac Arrest and ACLS Drugs, Bradycardia and Complete Heart Block, Antiarrhythmics, Anticoagulation in Atrial Fibrillation, Antianginals, ACS Therapy and Fibrinolysis, Pericarditis and Endocarditis Regimens 32.3 Cardiovascular Pharmacology II: Antihypertensives and Diuretics, Hypertensive Emergencies, Vasopressors and Inotropes in Shock, Heart Failure GDMT and Digoxin, and Lipid-Lowering Therapy 32.4 Nervous System Pharmacology I: Antiseizure Drugs and Status Epilepticus, Headache and Migraine, Vertigo, Stroke Thrombolysis and Secondary Prevention, Encephalopathy, Dementia, ADHD, Parkinson Disease and Movement Disorders, Raised Intracranial Pressure and CNS Infections
33 Chapter 33: Pharmacology II: Psychiatric, Respiratory & Genitourinary Therapeutics
33.1 Nervous System Pharmacology II: Antidepressants and Their Toxicity, Serotonin Syndrome, Anxiolytics and Hypnotics, Antipsychotics, EPS and NMS, Lithium and Mood Stabilizers, Sleep Disorders, Agitation and Alcohol Withdrawal 33.2 Respiratory Pharmacology: Cough and Colds, Allergic Rhinitis, Asthma (Controllers, Relievers, Exacerbations), COPD, Anti-TB Drugs, Antibiotics for Pneumonia and Bronchitis, and Lung Cancer Therapy 33.3 Genitourinary Pharmacology I: Antimicrobial Classes and Toxicities, and Drug Treatment of UTI, Pyelonephritis, Gonorrhea, Chlamydia, Syphilis, Genital Herpes, Genital Warts, PID, Vaginitis, Prostatitis and Orchitis 33.4 Genitourinary Pharmacology II: Kidney Stones, Nephrotic and Nephritic Disease, Drug Dosing in Kidney Disease and Hyperkalemia, Benign Prostatic Hyperplasia, Erectile Dysfunction, Renal Cell Carcinoma and Prostate Cancer Therapy
34 Chapter 34: Pharmacology III: Digestive, Endocrine, Skin & Musculoskeletal Therapeutics
34.1 Digestive Pharmacology: Portal Hypertension and Variceal Bleeding, Acid-Peptic Disease, H. pylori and GERD, Antiemetics, Laxatives and Antidiarrheals, Biliary and Pancreatic Disease, GI Infections and Parasites, Viral Hepatitis, C. difficile, Candidiasis and GI Cancer Chemotherapy 34.2 Endocrine Pharmacology I: Diabetes Mellitus Drugs (Metformin, Sulfonylureas, SGLT2 Inhibitors, GLP-1 Agonists, DPP-4 Inhibitors, Thiazolidinediones, Insulins), Choosing Therapy by Comorbidity, DKA and HHS, and Hypoglycemia 34.3 Endocrine Pharmacology II: Pituitary Disorders (GH Deficiency, Acromegaly, Prolactinoma, Diabetes Insipidus, Panhypopituitarism), Thyroid Drugs and Thyroid Storm, Calcium and Parathyroid Disorders, Adrenal Disorders and Corticosteroids 34.4 Cutaneous and Musculoskeletal Pharmacology: Cellulitis and Abscess, Drug-Induced Skin Reactions (SJS/TEN), Pain Management (Paracetamol, NSAIDs, Opioids), Osteoporosis, Rheumatoid Arthritis and Osteoarthritis, Septic and TB Arthritis, Gout, SLE and Psoriasis
35 Chapter 35: Surgery I: Basic Surgical Principles
35.1 Basic Surgical Principles I: The Surgery TOS, Fluids and Electrolytes, Acid-Base Balance, the Metabolic Response to Injury, Surgical Nutrition and Blood Transfusion 35.2 Basic Surgical Principles II: Shock and Surgical Critical Care, Hemorrhagic Shock and Massive Transfusion, ATLS Primary and Secondary Survey, Chest and Abdominal Trauma, Head and Spine Injury, Pelvic Fractures and Burns 35.3 Basic Surgical Principles III: Preoperative Assessment, Wound Healing, Surgical Infection and Asepsis, Postoperative Fever, Surgical Oncology, Immunology and Transplantation, Anesthesia and Patient Safety
36 Chapter 36: Surgery II: Abdomen, Breast & Hernia
36.1 Abdomen I: Esophagus (Hiatal Hernia, GERD, Achalasia, Caustic Injury, Barrett, Boerhaave, Mallory-Weiss, Cancer), Stomach and Duodenum (Peptic Ulcer Complications, Upper GI Bleeding, Gastric Cancer, GIST), Small Bowel (Obstruction, Ileus, Tumors, Typhoid and TB), Retroperitoneum and Abdominal Wall 36.2 Abdomen II: Gallstones, Cholecystitis, Choledocholithiasis and Cholangitis, Obstructive Jaundice, Liver (Cirrhosis, Portal Hypertension, Abscesses, Tumors and Hepatocellular Carcinoma), Pancreas (Acute and Chronic Pancreatitis, Pancreatic Cancer) and Spleen (Splenectomy, OPSI) 36.3 Abdomen III: Acute Appendicitis, Colonic Obstruction and Volvulus, Lower GI Bleeding, Diverticular Disease, Colorectal Polyps and Cancer, Hemorrhoids, Anal Fissure, Perianal Abscess and Fistula 36.4 Breast, Hernia and Skin and Soft Tissue: Benign Breast Masses, Breast Cancer Evaluation and Treatment, Groin and Abdominal Wall Hernias, Benign Skin and Soft-Tissue Tumors, Skin Cancers and Soft-Tissue Sarcoma
37 Chapter 37: Surgery III: Surgical Specialties
37.1 Head and Neck, Thyroid, Parathyroid, Endocrine and Bariatric Surgery and Otorhinolaryngology: Neck Masses and Head and Neck Cancer, Salivary Glands, Thyroid Nodules and Cancer, Goiter and Hyperthyroidism Surgery, Hyperparathyroidism, Adrenal Surgery, Bariatric Surgery, Nasal Polyps, Epistaxis, Vertigo, Hearing Loss and ENT Infections 37.2 Specialty I: Neurosurgery (Raised Intracranial Pressure and Herniation, Head Injury and Hematomas, Spontaneous Intracranial Hemorrhage, CNS and Peripheral Nerve Tumors, Spinal Cord Compression, Neurosurgical Infections) and Ophthalmology (Glaucoma, Cataract, Ophthalmic Emergencies) 37.3 Specialty II: Thoracic and Cardiovascular Surgery (Pleural Effusion and Empyema, Lung Cancer, Mediastinal Masses, Surgical Heart Disease, Aortic Aneurysm and Dissection, Peripheral Arterial and Venous Disease), Urology (Stones, Infections, Torsion, BPH, Urologic Tumors) and Gynecologic Surgery 37.4 Specialty III: Plastic and Reconstructive Surgery (Skin Grafts and Flaps, Cleft Lip and Palate, Facial Fractures, Hand Injuries), Orthopedics (Fractures, Dislocations, Bone and Joint Infections, Bone Tumors) and Pediatric Surgery (Hernias, CDH, Esophageal Atresia, Obstruction, Hirschsprung Disease, Neonatal Jaundice, Tumors)
38 Chapter 38: Medicine I: Cardiovascular, Digestive & Endocrine Medicine
38.1 Cardiovascular Medicine I: Hypertension and Secondary Causes, Dyslipidemia, Stable Angina and Acute Coronary Syndromes, Post-MI Complications, Heart Failure and Shock Syndromes 38.2 Cardiovascular Medicine II: Tachyarrhythmias and Bradyarrhythmias, Atrial Fibrillation, Sudden Cardiac Death and Brugada Syndrome, Cardiac Arrest, Valvular and Rheumatic Heart Disease, Infective Endocarditis, Myocarditis and Pericardial Disease 38.3 Gastroenterology and Hepatology: GERD and Peptic Ulcer Disease, Upper and Lower GI Bleeding, Diarrhea and GI Infections, Acute Pancreatitis and Biliary Disease, Viral Hepatitis, Cirrhosis and Portal Hypertension, Liver and GI Cancers 38.4 Endocrinology: Diabetes Mellitus Diagnosis, Treatment and Complications, DKA and HHS, Thyroid Disease, Pituitary Disorders, Adrenal Disorders (Cushing, Aldosteronism, Addison, Pheochromocytoma), Calcium and Parathyroid Disorders, Obesity and Metabolic Syndrome
39 Chapter 39: Medicine II: Hematology, Systemic Infections, Renal & Respiratory Medicine
39.1 Hematology, Immunology and Systemic Infections: Anemias (Iron Deficiency, Thalassemia, G6PD Deficiency, Megaloblastic, Hemolytic), Acute and Chronic Leukemias and Their Emergencies, Allergic Disorders, Dengue in Adults, COVID-19, Malaria and HIV/AIDS Opportunistic Infections 39.2 Nephrology: Acute Kidney Injury, Chronic Kidney Disease and Dialysis, Sodium and Potassium Disorders, Acid-Base Analysis, Urinary Tract Infections, Glomerular Diseases (Nephritic and Nephrotic), Kidney Stones, Renal Tumors and Sexually Transmitted Infections 39.3 Pulmonology and Critical Care: Acute Respiratory Failure and Oxygen Therapy, Bronchial Asthma, COPD, Community- and Hospital-Acquired Pneumonia, Pulmonary Tuberculosis and TB Infection, Pulmonary Embolism, Lung Cancer and ARDS
40 Chapter 40: Medicine III: Rheumatology, Dermatology, Neurology, Rehabilitation & Psychiatry
40.1 Rheumatology and Dermatology: Approach to Arthritis, Osteoarthritis, Rheumatoid Arthritis, Gout, Spondyloarthritis, SLE and Other Connective Tissue Diseases, Vasculitis and Myalgias, Bone Tumors, Common Skin Lesions, Skin Infections and Infestations, Eczema, Psoriasis, Severe Drug Eruptions and Skin Signs of Systemic Disease 40.2 Neurology and Rehabilitation Medicine: Stroke and TIA (Localization, Thrombolysis, Thrombectomy, Secondary Prevention), Intracranial Hemorrhage, Seizures and Status Epilepticus, Meningitis and Encephalitis, Tetanus and Rabies, Parkinsonism, Neuromuscular and Degenerative Diseases, Dementia, CNS Tumors, Post-Stroke Rehabilitation and Musculoskeletal Disorders 40.3 Psychiatry: Mental Status Examination, Depressive Disorders, Bipolar Disorder, Schizophrenia and Other Psychoses, Anxiety Disorders, OCD and Trauma-Related Disorders, Substance Use, and Acute Psychiatric Emergencies (Suicide Risk, Agitation, Withdrawal, Wernicke Encephalopathy)
13.4 Amino Acids & Proteins: Structure, Properties, Separation, Specialized Products, Collagen & Protein Misfolding in Alzheimer Disease
Key Takeaways Explain This Topic AI
The nine essential amino acids are phenylalanine, valine, threonine, tryptophan, isoleucine, methionine, histidine, leucine and lysine; leucine and lysine are purely ketogenic.
At its isoelectric point (pI) a protein has no net charge and does not move in an electric field; electrophoresis, chromatography, ultracentrifugation and salting out separate proteins by charge, size, density and solubility.
Serum protein electrophoresis shows albumin, alpha-1, alpha-2, beta and gamma bands; a narrow M spike in the gamma region suggests a plasma cell neoplasm, and a broad polyclonal rise suggests chronic inflammation or infection.
Collagen is Gly-X-Y triple helix; prolyl and lysyl hydroxylases need vitamin C and iron, lysyl oxidase needs copper; defects cause scurvy, osteogenesis imperfecta (type I), Ehlers-Danlos syndromes and Menkes disease.
Alzheimer disease involves amyloid-beta from APP cleavage, tau tangles, the APOE e4 allele and a cholinergic deficit, which acetylcholinesterase inhibitors partly offset.
Last updated: October 2026
Why this area matters
The TOS lists "amino acid and protein biochemistry (structure, function, properties, denaturation, fractionation, chemical reactions, separation), collagen, Alzheimer's disease". Expect items on:
- the charge of amino acids at a given pH;
- what denaturation destroys;
- reading a serum protein electrophoresis;
- matching a collagen defect to its disease;
the molecular basis of Alzheimer disease.
Hierarchy of Protein Architecture and Conformational Dynamics
Proteins fold into thermodynamically stable native conformations structured across four discrete organizational tiers:
Primary Structure: The linear sequence of amino acids linked covalently by peptide bonds (amide linkages connecting the α \alpha α -carboxyl group of one amino acid to the α \alpha α -amino group of the next). Peptide bonds possess partial double-bond character (40% resonance stabilization) that restricts rotation, maintaining a rigid, planar trans configuration.
Secondary Structure: Local spatial arrangements of the polypeptide backbone stabilized strictly by hydrogen bonds between carbonyl oxygens ( C = O C=O C = O ) and amide nitrogens ( N − H N-H N − H ):
α \alpha α -Helix: Right-handed spiral with 3.6 3.6 3.6 amino acids per turn. Hydrogen bonds form between the C = O C=O C = O of residue n n n and the N − H N-H N − H of residue n + 4 n+4 n + 4 . Proline acts as an " α \alpha α -helix breaker" because its rigid cyclic pyrrolidine ring introduces a steric kink and lacks a free amide hydrogen for hydrogen bonding. Glycine can also disrupt helices due to excessive conformational flexibility.
β \beta β -Pleated Sheet: Extended parallel or antiparallel polypeptide strands stabilized by interchain hydrogen bonds perpendicular to the polypeptide backbone.
Tertiary Structure: The overall three-dimensional folding of a single polypeptide chain into domain structures. Stabilized by hydrophobic interactions (burying nonpolar side chains in the core), electrostatic salt bridges (between positively charged Lys/Arg/His and negatively charged Asp/Glu), hydrogen bonds, and covalent disulfide bonds formed between cysteine sulfhydryl groups via oxidation.
Quaternary Structure: The spatial assembly of two or more independent polypeptide subunits into a multimeric functional complex (e.g., adult hemoglobin α 2 β 2 \alpha_2\beta_2 α 2 β 2 heterotetramer).
Molecular Chaperones, Misfolding Pathologies, and Amyloidosis
Proper conformational folding is guided by molecular chaperones, including Heat Shock Proteins (HSP70, HSP60) , which bind exposed hydrophobic segments of nascent polypeptides to prevent inappropriate aggregation. When protein quality control fails, misfolded proteins aggregate into insoluble fibrillar structures dominated by antiparallel cross- β \beta β -pleated sheets , termed amyloid .
Amyloid deposits resist endogenous proteolysis and disrupt organ function. Histologically, amyloid binds Congo red dye , demonstrating pathognomonic apple-green birefringence under polarized light microscopy:
AL Amyloidosis (Primary): Deposition of monoclonal immunoglobulin light chains ( κ \kappa κ or λ \lambda λ ) produced in plasma cell dyscrasias (multiple myeloma).
AA Amyloidosis (Secondary): Deposition of Serum Amyloid A (SAA), an acute-phase reactant synthesized in the liver during chronic inflammatory states (tuberculosis, bronchiectasis, rheumatoid arthritis).
A β A\beta A β Amyloidosis: Deposition of β \beta β -amyloid cleaved from Amyloid Precursor Protein (APP) on chromosome 21, forming senile plaques in Alzheimer disease and Down syndrome.
β 2 \beta_2 β 2 -Microglobulin Amyloidosis: Accumulation of MHC Class I light chains in patients undergoing long-term hemodialysis, causing carpal tunnel syndrome and destructive spondyloarthropathy.
Amino Acid Nutritional and Metabolic Classification
All standard 20 amino acids feature a chiral α \alpha α -carbon (except glycine). They are categorized according to nutritional essentiality and the metabolic destinations of their carbon skeletons:
Essential versus Non-Essential Amino Acids
Nine amino acids cannot be synthesized de novo in humans and must be supplied in the diet:
Mnemonic: "PVT TIM HaLL" (Phenylalanine, Valine, Threonine, Tryptophan, Isoleucine, Methionine, Histidine, Leucine, Lysine).
Glucogenic versus Ketogenic Amino Acids
Classification Amino Acid Members Metabolic Fate of Carbon Skeletons
Purely Ketogenic Leucine and Lysine Converted exclusively to Acetyl-CoA and Acetoacetate ; cannot generate glucose via gluconeogenesis; safe in PDH deficiency
Both Glucogenic and Ketogenic Phenylalanine, Isoleucine, Threonine, Tryptophan, Tyrosine ( Mnemonic: "PITT-T") Yield both acetyl-CoA/acetoacetate and gluconeogenic intermediates (pyruvate, fumarate, succinyl-CoA)
Purely Glucogenic All remaining 13 amino acids (Alanine, Arginine, Asparagine, Aspartate, Cysteine, Glutamate, Glutamine, Glycine, Histidine, Methionine, Proline, Serine, Valine) Converted into pyruvate or Krebs cycle intermediates ( α \alpha α -ketoglutarate, succinyl-CoA, fumarate, oxaloacetate) for glucose synthesis
Net Charge at Physiologic pH (7.4)
Acidic Amino Acids (Negatively Charged): Aspartate ( p K a ≈ 3.9 \text{p}K_a \approx 3.9 p K a ≈ 3.9 ) and Glutamate ( p K a ≈ 4.1 \text{p}K_a \approx 4.1 p K a ≈ 4.1 ).
Basic Amino Acids (Positively Charged): Lysine ( p K a ≈ 10.5 \text{p}K_a \approx 10.5 p K a ≈ 10.5 ), Arginine ( p K a ≈ 12.5 \text{p}K_a \approx 12.5 p K a ≈ 12.5 , the most basic amino acid), and Histidine ( p K a ≈ 6.0 \text{p}K_a \approx 6.0 p K a ≈ 6.0 ). Because histidine's imidazole side chain has a p K a \text{p}K_a p K a near physiological pH, it can rapidly exchange protons, making it a critical catalytic residue in enzyme active sites and the primary protein buffer in hemoglobin.
Physical properties, denaturation and separation
Isoelectric point (pI): the pH at which a molecule carries no net charge.
Below its pI, a protein is positively charged and moves to the cathode; above its pI it is negative and moves to the anode.
At physiologic pH (7.4), most plasma proteins are negatively charged, because their pI is about 5 to 6.
Solubility is lowest at the pI, which is used in isoelectric precipitation.
Denaturation: loss of secondary, tertiary and quaternary structure, with peptide bonds intact , so the primary structure survives. It is caused by heat, extreme pH, organic solvents, urea, detergents and heavy metals. Biological activity is lost. It is sometimes reversible (ribonuclease refolding), but usually not, as when egg white is cooked. Denatured proteins are more easily digested, which is one reason cooking helps.
Chemical reactions and assays:
Biuret (peptide bonds) and Lowry methods measure total protein.
Ninhydrin detects free amino groups.
Sanger and Edman reagents identify N-terminal residues.
Fractionation and separation:
- Method Property used Example
- Salting out (ammonium sulfate) Solubility Separating globulins (precipitate at lower salt) from albumin
- Dialysis Size (semipermeable membrane) Removing small molecules
- Ultracentrifugation Size, shape and density (Svedberg units) Lipoprotein classes; ribosomal subunits
- Gel-filtration (size-exclusion) chromatography Size Large proteins elute first
- Ion-exchange chromatography Charge Hemoglobin variants; HbA1c
- Affinity chromatography Specific binding Antibody purification
Electrophoresis (paper, agarose, SDS-PAGE, isoelectric focusing) Charge and size Serum protein electrophoresis, hemoglobin electrophoresis, Western blot
Serum protein electrophoresis (anode to cathode):
Albumin: the largest band. It falls in liver disease, nephrotic syndrome and malnutrition.
Alpha-1: alpha-1-antitrypsin. It is low in AAT deficiency.
Alpha-2: haptoglobin, alpha-2-macroglobulin, ceruloplasmin. It rises in inflammation and nephrotic syndrome.
Beta: transferrin, C3, LDL. Transferrin rises in iron deficiency.
Gamma: immunoglobulins.
A narrow monoclonal (M) spike suggests myeloma or MGUS.
A broad polyclonal increase suggests chronic infection, autoimmunity or cirrhosis; cirrhosis also shows beta-gamma bridging from IgA.
Low gamma suggests agammaglobulinemia.
Connective Tissue Architecture & Collagen Biochemistry
Connective tissue consists of cells (fibroblasts, adipocytes, macrophages, mast cells) suspended within an abundant extracellular matrix (ECM) composed of ground substance (glycosaminoglycans like hyaluronic acid, chondroitin sulfate; proteoglycans; multiadhesive glycoproteins like fibronectin and laminin) and structural fibers.
The Major Collagen Subtypes
Collagen is the most abundant protein in the human body, synthesized as procollagen triple helices containing repeating Gly-X-Y amino acid sequences (where X is typically proline and Y is hydroxyproline or hydroxylysine). Intracellular hydroxylation of proline and lysine requires ascorbic acid (vitamin C); failure of this step leads to impaired triple-helix hydrogen bonding and clinical scurvy (poor wound healing, gum bleeding, perifollicular hemorrhages).
Type I Collagen :
Distribution : 90% of total bodily collagen. Present in bone (organic osteoid), skin dermis , tendons , ligaments , fascia , cornea , dentin , and mature scar tissue during late wound remodeling ( > 3 weeks > 3\text{ weeks} > 3 weeks post-injury).
Clinical Pathology : Mutational defects in COL1A1 or COL1A2 genes cause Osteogenesis Imperfecta (autosomal dominant; recurrent pathological fractures with minimal trauma, blue sclerae due to translucent choroidal visualization, hearing loss from stapes footplate ankylosis, and opalescent teeth in dentinogenesis imperfecta).
Type II Collagen :
Distribution : Chief fibrillar constituent of hyaline cartilage , elastic cartilage , the vitreous body of the eye , and the nucleus pulposus of the intervertebral disc ("car-two-lage").
Function : Resists intermittent compressive loads in articular joints.
Type III Collagen (Reticulin) :
Distribution : Forms delicate, pliable argyrophilic reticular fiber meshes in highly distensible, cellular organs: blood vessel walls (aorta, muscular arteries), dermis , uterus , lymphoid organs (spleen, lymph nodes), and early granulation tissue (synthesized rapidly during early wound repair before enzymatic replacement by Type I collagen).
Clinical Pathology : Mutations in COL3A1 cause Vascular Ehlers-Danlos Syndrome (Type IV EDS; arterial aneurysm rupture, spontaneous bowel perforation, and gravid uterine rupture due to vascular fragility).
Type IV Collagen :
Distribution : Forms the non-fibrillar, two-dimensional sheet meshwork of the basal lamina (lamina densa) underlying all epithelia, surrounding muscle cells, and forming the renal glomerular basement membrane (GBM) ("Type four on the floor").
Clinical Pathology :
Alport Syndrome : X-linked defect in the α 5 \alpha_5 α 5 chain of Type IV collagen ( COL4A5 ), manifesting as progressive hereditary nephritis with microhematuria, sensorineural hearing loss, and ocular abnormalities (anterior lenticonus).
Goodpasture Syndrome : Autoantibodies directed against the non-collagenous NC1 domain of the α 3 \alpha_3 α 3 chain of Type IV collagen, causing rapidly progressive glomerulonephritis and pulmonary alveolar hemorrhage with linear IgG immunofluorescence.
Collagen synthesis step by step
Translation of pre-procollagen alpha chains on the rough ER.
Hydroxylation of proline and lysine by prolyl and lysyl hydroxylases. These need vitamin C, Fe2+, O2 and alpha-ketoglutarate ; vitamin C deficiency causes scurvy .
Glycosylation of hydroxylysine.
Assembly of the procollagen triple helix , stabilized by hydrogen bonds. Osteogenesis imperfecta mutations disrupt this; glycine substitutions are the most severe.
Secretion into the extracellular space and cleavage of the terminal propeptides. Defective cleavage causes some forms of Ehlers-Danlos syndrome.
Cross-linking by lysyl oxidase , a copper -dependent enzyme. Menkes disease (an X-linked copper-transport defect, ATP7A ) causes brittle "kinky" hair, hypotonia and arterial fragility.
Elastin , rich in glycine and proline but not hydroxylated, is cross-linked through desmosine . Fibrillin-1 is its scaffold, and Marfan syndrome is caused by fibrillin-1 mutations.
Specialized Products Derived from Amino Acids
Precursor Amino Acid Primary Biosynthetic Derivatives Key Enzymes / Required Cofactors Clinical and Pathological Relevance
Tyrosine Catecholamines (Dopamine, Norepinephrine, Epinephrine) Tyrosine Hydroxylase ( B H 4 BH_4 B H 4 ); DOPA Decarboxylase (PLP/B6); Dopamine β \beta β -Hydroxylase (Vit C); PNMT (SAM) Rate-limiting enzyme is Tyrosine Hydroxylase; PNMT is induced by cortisol; pheochromocytoma hypersecretion
Tyrosine Melanin Tyrosinase (Copper-dependent) Deficiency of tyrosinase causes Oculocutaneous Albinism ; increased melanoma risk
Tyrosine Thyroid Hormones ( T 3 , T 4 T_3, T_4 T 3 , T 4 ) Thyroid peroxidase (Iodine) Hypothyroidism and endemic goiter
Tryptophan Serotonin and Melatonin Tryptophan Hydroxylase ( B H 4 BH_4 B H 4 ); DOPA Decarboxylase (PLP/B6) Carcinoid syndrome produces massive serotonin; cutaneous flushing, diarrhea, tricuspid regurgitation
Tryptophan Niacin (Vitamin B3) Requires Vitamin B2 (FAD) and Vitamin B6 (PLP) cofactors Hartnup disease or carcinoid syndrome can precipitate secondary pellagra
Histidine Histamine Histidine Decarboxylase (PLP/B6) Mediates type I hypersensitivity reactions, vasodilation, and gastric acid secretion
Glycine Heme δ \delta δ -Aminolevulinic Acid (ALA) Synthase (PLP/B6) Committed step of heme synthesis; inhibited by lead and heme; sideroblastic anemia
Glycine Purine rings, Creatine, Glutathione Multistep pathways Precursor for nucleosides, high-energy phosphate buffer, and cellular antioxidant
Arginine Nitric Oxide (NO) Nitric Oxide Synthase (NOS) ( B H 4 BH_4 B H 4 , NADPH, FAD, FMN) Potent endothelial vasodilator; inhibits platelet aggregation
Arginine Urea, Creatine, Agmatine Arginase, amidinotransferase Intermediary in nitrogen clearance and bioenergetics
Glutamate GABA ( γ \gamma γ -Aminobutyric Acid) Glutamate Decarboxylase (PLP/B6) Primary inhibitory neurotransmitter of the CNS; Vitamin B6 deficiency causes intractable neonatal seizures
Glutamate Glutathione (GSH) Glutamate-cysteine ligase, glutathione synthetase Universal tripeptide antioxidant ( γ \gamma γ -Glu-Cys-Gly)
Protein misfolding and Alzheimer disease
Amyloid-beta: amyloid precursor protein (APP, chromosome 21) is normally cut by alpha-secretase. Sequential cleavage by beta-secretase and gamma-secretase (presenilins) instead releases amyloid-beta 42 , which aggregates into extracellular neuritic plaques and vessel-wall amyloid.
Tau: hyperphosphorylated tau , a microtubule-associated protein, forms intracellular neurofibrillary tangles , which correlate best with dementia severity.
Genetic risk:
early-onset familial disease: mutations of APP , PSEN1 or PSEN2 ; trisomy 21 adds an APP copy;
late-onset disease: APOE e4 raises risk, and APOE e2 is protective.
Neurochemistry: loss of cholinergic neurons in the nucleus basalis of Meynert lowers acetylcholine.
Acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine) give modest symptomatic benefit.
Memantine (an NMDA antagonist) limits glutamate excitotoxicity.
Anti-amyloid antibodies remove plaque but carry a risk of brain swelling and hemorrhage (ARIA).
Other misfolding diseases:
- prion diseases (Creutzfeldt-Jakob: PrP-sc converts normal prion protein);
- Parkinson disease (alpha-synuclein);
- Huntington disease (polyglutamine);
alpha-1-antitrypsin deficiency (misfolded protein trapped in hepatocytes).